Epirubicin
- Generic Name
- Epirubicin
- Brand Names
- Ellence, Pharmorubicin PFS
- Drug Type
- Small Molecule
- Chemical Formula
- C27H29NO11
- CAS Number
- 56420-45-2
- Unique Ingredient Identifier
- 3Z8479ZZ5X
Overview
An anthracycline which is the 4'-epi-isomer of doxorubicin. The compound exerts its antitumor effects by interference with the synthesis and function of DNA.
Background
An anthracycline which is the 4'-epi-isomer of doxorubicin. The compound exerts its antitumor effects by interference with the synthesis and function of DNA.
Indication
For use as a component of adjuvant therapy in patients with evidence of axillary node tumor involvement following resection of primary breast cancer.
Associated Conditions
- Breast Cancer
- Breast Cancer, Stage II
- Breast Cancer, Stage III
- Colorectal Cancer
- Hormone-Refractory Prostate Cancer
- Neoplasm of Stomach
- Non-Small Cell Lung Carcinoma
- Ovarian Cancer
- Papillary transitional cell carcinoma of bladder
- Recurrent Superficial Bladder Cancer
- Small Cell Lung Cancer (SCLC)
- Soft Tissue Sarcoma
- Carcinoma in situ of urinary bladder
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath